Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 2
2006 2
2009 2
2010 2
2011 3
2012 3
2013 5
2014 8
2015 6
2016 2
2017 6
2018 2
2019 3
2020 2
2021 7
2022 9
2023 5
2024 6
2025 8
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Connors JM, et al. N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. N Engl J Med. 2018. PMID: 29224502 Free PMC article. Clinical Trial.
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial.
Falchi L, Nijland M, Huang H, Linton KM, Seymour JF, Tao R, Kwiatek M, Costa A, Vassilakopoulos TP, Greil R, Jiménez-Ubieto A, Gangatharan SA, Benjamini O, Thieblemont C, Tucci A, Elinder-Camburn A, Illes A, Novak J, Pavlovsky MA, McDonald A, Yoon DH, Maruyama D, Sunkersett G, Mei JP, Mukherjee N, Zhu F, Alshreef A, Favaro E, Morschhauser F; EPCORE FL-1 Investigators. Falchi L, et al. Lancet. 2026 Jan 10;407(10524):161-173. doi: 10.1016/S0140-6736(25)02360-8. Epub 2025 Dec 7. Lancet. 2026. PMID: 41371238 Free article. Clinical Trial.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI).
Pascual-Izquierdo C, Sánchez-González B, Canaro-Hirnyk MI, García-Donas G, Menor-Gómez M, Gil-Fernández JJ, Monsalvo-Saornil S, de-Laiglesia A, Álvarez-Román MT, Jarque-Ramos I, Llácer MJ, Pedrote-Amador B, Zafra-Torres D, Caparrós-Miranda I, Ortúzar-Pasalodos A, Revilla-Calvo N, Bastida JM, Chica-Gullón E, Alvarellos M, Jiménez-Bárcenas R, Bernat S, Martínez-Carballeira D, Lakhwani S, López-Ansoar E, Moreno-Beltrán ME, Lorenzo-Vizcaya Á, Aguirre MA, Lasa-Eguialde M, Canet M, González-Gascón-Y-Marín IT, Caballero-Navarro G, Cuesta A, Díaz-López M, Arquero T, Moreno-Carbonell M, Mingot-Castellano ME; Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH). Pascual-Izquierdo C, et al. Among authors: sanchez gonzalez b. Am J Hematol. 2024 Dec;99(12):2328-2339. doi: 10.1002/ajh.27498. Epub 2024 Oct 12. Am J Hematol. 2024. PMID: 39394928 Free article.
COVID-19 Vaccines and Autoimmune Hematologic Disorders.
Mingot-Castellano ME, Butta N, Canaro M, Gómez Del Castillo Solano MDC, Sánchez-González B, Jiménez-Bárcenas R, Pascual-Izquierdo C, Caballero-Navarro G, Entrena Ureña L, José González-López T, On Behalf Of The Gepti. Mingot-Castellano ME, et al. Among authors: sanchez gonzalez b. Vaccines (Basel). 2022 Jun 16;10(6):961. doi: 10.3390/vaccines10060961. Vaccines (Basel). 2022. PMID: 35746569 Free PMC article. Review.
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.
Newland AC, Sánchez-González B, Rejtő L, Egyed M, Romanyuk N, Godar M, Verschueren K, Gandini D, Ulrichts P, Beauchamp J, Dreier T, Ward ES, Michel M, Liebman HA, de Haard H, Leupin N, Kuter DJ. Newland AC, et al. Among authors: sanchez gonzalez b. Am J Hematol. 2020 Feb;95(2):178-187. doi: 10.1002/ajh.25680. Epub 2019 Dec 10. Am J Hematol. 2020. PMID: 31821591 Free PMC article. Clinical Trial.
[Sarcoidosis-lymphoma syndrome].
Giralt L, Sánchez-Font A, Sánchez-González B, Balcells E. Giralt L, et al. Among authors: sanchez gonzalez b. Med Clin (Barc). 2015 Sep 21;145(6):276-7. doi: 10.1016/j.medcli.2014.11.010. Epub 2015 Jan 8. Med Clin (Barc). 2015. PMID: 25579775 Spanish. No abstract available.
Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE Study.
Sureda A, García-Sanz R, Domingo-Domenech E, Capote FJ, Gutiérrez A, Rodriguez A, Aguiar D, Giraldo P, Infante MS, López-Jiménez J, Martínez C, Sánchez-González B, Ortiz-Romero PL, Grande M, Baeza-Montañez L. Sureda A, et al. Among authors: sanchez gonzalez b. Cancers (Basel). 2025 Mar 28;17(7):1137. doi: 10.3390/cancers17071137. Cancers (Basel). 2025. PMID: 40227660 Free PMC article.
Novel Therapies to Address Unmet Needs in ITP.
Mingot-Castellano ME, Bastida JM, Caballero-Navarro G, Entrena Ureña L, González-López TJ, González-Porras JR, Butta N, Canaro M, Jiménez-Bárcenas R, Gómez Del Castillo Solano MDC, Sánchez-González B, Pascual-Izquierdo C, On Behalf Of The Gepti. Mingot-Castellano ME, et al. Among authors: sanchez gonzalez b. Pharmaceuticals (Basel). 2022 Jun 23;15(7):779. doi: 10.3390/ph15070779. Pharmaceuticals (Basel). 2022. PMID: 35890078 Free PMC article. Review.
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI).
Mingot-Castellano ME, Canaro Hirnyk M, Sánchez-González B, Álvarez-Román MT, Bárez-García A, Bernardo-Gutiérrez Á, Bernat-Pablo S, Bolaños-Calderón E, Butta-Coll N, Caballero-Navarro G, Caparrós-Miranda IS, Entrena-Ureña L, Fernández-Fuertes LF, García-Frade LJ, Gómez Del Castillo MDC, González-López TJ, Grande-García C, Guinea de Castro JM, Jarque-Ramos I, Jiménez-Bárcenas R, López-Ansoar E, Martínez-Carballeira D, Martínez-Robles V, Monteagudo-Montesinos E, Páramo-Fernández JA, Perera-Álvarez MDM, Soto-Ortega I, Valcárcel-Ferreiras D, Pascual-Izquierdo C; Spanish Immune Thrombocytopenia Group (GEPTI). Mingot-Castellano ME, et al. Among authors: sanchez gonzalez b. J Clin Med. 2023 Oct 10;12(20):6422. doi: 10.3390/jcm12206422. J Clin Med. 2023. PMID: 37892566 Free PMC article. Review.
74 results